Learn More
Objective. To perform a cost‐effectiveness analysis (CEA) between a standard antiemetic regimen ‐chlorpromazine + dexamethasone (CPM‐DEX)‐ and a 5‐HT3 receptor antagonist ‐tropisetron (TROP)‐ in the(More)